Feedback / Questions
nuvisertib (TP-3654) - Sumitomo Pharma
Nuvisertib: Launch in US/Japan for myelofibrosis in FY 2028
(Sumitomo Pharma)
-
Jan 30, 2026 -
Q3 FY2025 Results
Launch Japan • Launch US
•
Myelofibrosis • Oncology
https://www.sumitomo-pharma.com/ir/library/presentation/assets/pdf/eir20260130.pdf
Jan 30, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious